78 related articles for article (PubMed ID: 2697007)
1. The influence of diagnosis and family treatment on acute treatment response and short term outcome in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group.
Keith SJ; Bellack A; Frances A; Mance R; Matthews S
Psychopharmacol Bull; 1989; 25(3):336-9. PubMed ID: 2697007
[No Abstract] [Full Text] [Related]
2. Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group.
Schooler NR; Keith SJ; Severe JB; Matthews S
Psychopharmacol Bull; 1989; 25(3):331-5. PubMed ID: 2576316
[No Abstract] [Full Text] [Related]
3. Predicting medication-free treatment response in acute psychosis: cross-validation from the Finnish Need-Adapted Project.
Bola JR; Lehtinen K; Aaltonen J; Räkköläinen V; Syvälahti E; Lehtinen V
J Nerv Ment Dis; 2006 Oct; 194(10):732-9. PubMed ID: 17041284
[TBL] [Abstract][Full Text] [Related]
4. Schizophrenia.
Lawrie S; McIntosh A
Clin Evid; 2002 Jun; (7):920-44. PubMed ID: 12230716
[No Abstract] [Full Text] [Related]
5. Control group bias in randomized atypical antipsychotic medication trials for schizophrenia.
Woods SW; Gueorguieva RV; Baker CB; Makuch RW
Arch Gen Psychiatry; 2005 Sep; 62(9):961-70. PubMed ID: 16143728
[TBL] [Abstract][Full Text] [Related]
6. Systemic family therapy in schizophrenia: a randomized clinical trial of effectiveness.
Bressi C; Manenti S; Frongia P; Porcellana M; Invernizzi G
Psychother Psychosom; 2008; 77(1):43-9. PubMed ID: 18087207
[TBL] [Abstract][Full Text] [Related]
7. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
8. The rationale for early intervention in schizophrenia and related disorders.
Nordentoft M; Jeppesen P; Petersen L; Bertelsen M; Thorup A
Early Interv Psychiatry; 2009 Sep; 3 Suppl 1():S3-7. PubMed ID: 21352194
[TBL] [Abstract][Full Text] [Related]
9. Relapse prevention in schizophrenia: evidence from longterm, randomized, double-blind clinical trials.
Pecenak J
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():49-70. PubMed ID: 17262007
[TBL] [Abstract][Full Text] [Related]
10. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
11. Oral ziprasidone in the treatment of schizophrenia: a review of short-term trials.
Kane JM
J Clin Psychiatry; 2003; 64 Suppl 19():19-25. PubMed ID: 14728086
[TBL] [Abstract][Full Text] [Related]
12. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
[TBL] [Abstract][Full Text] [Related]
13. [Quetiapine in the treatment of acute mania].
Bräunig P
Psychiatr Prax; 2006 Mar; 33 Suppl 1():S27-31. PubMed ID: 16511728
[TBL] [Abstract][Full Text] [Related]
14. [Maintenance electroconvulsive therapy and treatment of refractory schizophrenia].
Lévy-Rueff M; Jurgens A; Lôo H; Olié JP; Amado I
Encephale; 2008 Oct; 34(5):526-33. PubMed ID: 19068343
[TBL] [Abstract][Full Text] [Related]
15. [Does psychoeducational family intervention improve outcome of schizophrenia?].
Bentsen H
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2571-4. PubMed ID: 14714045
[TBL] [Abstract][Full Text] [Related]
16. Four-week, double-blind, placebo- and ziprasidone-controlled trial of iloperidone in patients with acute exacerbations of schizophrenia.
Cutler AJ; Kalali AH; Weiden PJ; Hamilton J; Wolfgang CD
J Clin Psychopharmacol; 2008 Apr; 28(2 Suppl 1):S20-8. PubMed ID: 18334909
[TBL] [Abstract][Full Text] [Related]
17. Amisulpride augmentation in patients with schizophrenia partially responsive or unresponsive to clozapine. A randomized, double-blind, placebo-controlled trial.
Assion HJ; Reinbold H; Lemanski S; Basilowski M; Juckel G
Pharmacopsychiatry; 2008 Jan; 41(1):24-8. PubMed ID: 18203048
[TBL] [Abstract][Full Text] [Related]
18. Antipsychotic effects of verapamil in schizophrenia.
Price WA
Hillside J Clin Psychiatry; 1987; 9(2):225-30. PubMed ID: 3323023
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia.
Gaebel W; Möller HJ; Buchkremer G; Ohmann C; Riesbeck M; Wölwer W; Von Wilmsdorff M; Bottlender R; Klingberg S
Eur Arch Psychiatry Clin Neurosci; 2004 Apr; 254(2):129-40. PubMed ID: 15146342
[TBL] [Abstract][Full Text] [Related]
20. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
